USPSTF: Evidence Lacking on Screening for AFib With ECG
On Aug. 7, the U.S. Preventive Services Task Force posted a final recommendation statement and final evidence summary on screening for atrial fibrillation with electrocardiography to prevent stroke. (Source: AAFP News)
Source: AAFP News - August 15, 2018 Category: Primary Care Source Type: news

Case in Point: Would You Anticoagulate this Patient?
The patient is an elderly man with ESRD on dialysis who goes into atrial fibrillation during fistula declotting. How to proceed? (Source: ConsultantLive)
Source: ConsultantLive - August 14, 2018 Category: Internal Medicine Authors: Payal Kohli, MD Tags: Atrial Fibrillation Source Type: news

Afib and Aflutter: Should We Be “Lumpers” or “Splitters”?
Results of a new study may prompt you to rethink how you approach anticoagulation for these 2 arrhythmias. Are they 1 entity, or 2? (Source: ConsultantLive)
Source: ConsultantLive - August 13, 2018 Category: Internal Medicine Authors: Payal Kohli, MD Tags: Atrial Fibrillation Source Type: news

Complication Risk From RA Ablation Said to Deserve Scrutiny Complication Risk From RA Ablation Said to Deserve Scrutiny
Surprisingly high complication risks from ablation for atrial fibrillation or atrial flutter, especially for isolated right atrial procedures and at low-volume centers, were seen in a German registry.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 13, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Perspectives on USPSTF A-Fib Screening Recommendation
THURSDAY, Aug. 9, 2018 -- The U.S. Preventive Service Task Force published a final recommendation on Aug. 7 citing insufficient evidence to assess the benefits and harms of screening for atrial fibrillation (AF) with electrocardiography (ECG) in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 9, 2018 Category: Pharmaceuticals Source Type: news

USPSTF: Insufficient Evidence to Screen for Atrial Fibrillation
THURSDAY, Aug. 9, 2018 -- There is insufficient evidence to support screening for atrial fibrillation (AF) with electrocardiography (ECG) in older, asymptomatic patients, according to a U.S. Preventive Services Task Force (USPSTF) final... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 9, 2018 Category: Pharmaceuticals Source Type: news

Stroke Risk Lower in Atrial Flutter Than Atrial Fibrillation Stroke Risk Lower in Atrial Flutter Than Atrial Fibrillation
The same stratification and treatment approaches are used for atrial fibrillation and atrial flutter in stroke prevention, but a new study suggests they should be assessed and treated differently.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 8, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Echocardiography reveals effects of pre-eclampsia
Echocardiography of pregnant women with pre-eclampsia has shown that the condition...Read more on AuntMinnie.comRelated Reading: CCTA biomarker spots high-risk plaques in heart disease VR, AR may revamp cardiovascular imaging Stress echo beats CCTA for evaluating chest pain Will ultrasound and AI become the tricorder of the future? Echocardiography technique can guide atrial fibrillation ablation (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 7, 2018 Category: Radiology Source Type: news

Medical News Today: Scientists link 151 genes to atrial fibrillation
A study of biobank genomic data totaling more than 1 million people identifies 151 candidate genes that are likely associated with atrial fibrillation. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - August 6, 2018 Category: Consumer Health News Tags: Heart Disease Source Type: news

Have We Reached the Point of Primary Prevention for AF? Have We Reached the Point of Primary Prevention for AF?
Should we offer primary prevention therapy for patients at risk of atrial fibrillation, even before the arrhythmia has occurred? What are the risks, and which patients would benefit?Journal of Cardiovascular Electrophysiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 6, 2018 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Smoking Linked to Increased Atrial Fibrillation Risk Smoking Linked to Increased Atrial Fibrillation Risk
Current smokers are more likely than nonsmokers to develop atrial fibrillation, suggests an analysis of existing research.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 3, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Atrial Fibrillation: What's New? Not Much Atrial Fibrillation: What's New? Not Much
An investigation of AF trials on ClinicalTrials.gov found few studies of high scientific rigor. John Mandrola, MD, ponders the implications for patient management.theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 3, 2018 Category: Consumer Health News Tags: Cardiology Expert Column Source Type: news

Smoking linked to increased atrial fibrillation risk
(Reuters Health) - Current smokers are more likely than nonsmokers to develop the most common heart rhythm disorder, atrial fibrillation, suggests an analysis of existing research. (Source: Reuters: Health)
Source: Reuters: Health - August 2, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Big-data study pinpoints more than 150 genes associated with atrial fibrillation
(Michigan Medicine - University of Michigan) Drawing on genomic data from more than one million individuals, researchers from the University of Michigan have led a large collaborative effort to discover as-yet unknown genetic risk factors for atrial fibrillation: An irregular, often rapid heart rate affecting millions of Americans and more than 30 million people worldwide. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 2, 2018 Category: International Medicine & Public Health Source Type: news

Apixaban for AF in ESRD: Fewer Strokes, Major Bleeds vs Warfarin Apixaban for AF in ESRD: Fewer Strokes, Major Bleeds vs Warfarin
' I think this is the best data we have so far'supporting the use of apixaban in the especially high-risk population with atrial fibrillation, the lead researcher concludes. A randomized trial is forthcoming.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 31, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

Colorado biotech company's shares soaring after getting good news from FDA
Shares in Arca Biopharma Inc. were soaring Tuesday after the Westminster biotech received good news from the U.S. Food and Drug Administration. Arca Biopharma (Nasdaq: ABIO) announced a "positive outcome of (an) end-of-phase 2 meeting with" the FDA regarding Gencaro treatment for atrial fibrillation (AF) patients with heart failure (HF). Arca Biopharma said it anticipates initiating a Phase 3 clinical trial "subject to securing additiona l financing through a strategic partnership and/or additional… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 31, 2018 Category: Pharmaceuticals Authors: Ben Miller Source Type: news

Thermedical wins FDA nod for Durablate catheter trial
Thermedical said today that it won an investigational device exemption from the FDA for a clinical trial of its Durablate catheter for treating ventricular tachycardia. The Durablate catheter is designed to simultaneously inject hot saline and use radiofrequency energy to effect the ablation; the Thermedical claims that the method is 20 times more effective than conventional RF ablation. The Waltham, Mass.-based company said the 30-patient early feasibility study is designed for patients already implanted with an implantable cardioverter defibrillator who’ve also had a conventional VT ablation procedure tha...
Source: Mass Device - July 31, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Cardiovascular Catheters Clinical Trials atrial fibrillation Thermedical Source Type: news

Genetic basis of heart rhythms explored in large population study
(University of Washington Health Sciences/UW Medicine) New information about the biology behind the heart's electrical activity has been revealed in a major genome study with the largest sample size ever of a project of this type. These molecular mechanisms offer insights into cardiac electrical diseases and could suggest avenues of drug research for preventing and treating heart rhythm or conduction problems. Genes in 44 loci identified as associated with the PR interval on an EKG are overrepresented in cardiac disease processes, including heart block, sick sinus syndrome, and atrial fibrillation. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 27, 2018 Category: International Medicine & Public Health Source Type: news

Bioelectronics: A New era in Medical Care Is on the Horizon
Bioelectronics, generally defined, isn't new. Doctors Rune Elmqvist and Ake Senning implanted the first pacemaker in 1958. FDA approved the first spinal cord stimulator (SCS) in 1989. While both solutions continue to help patients worldwide, smaller, more advanced technology has pushed bioelectronics into a new era. Researchers have developed novel methods to use electrical impulses to regulate the brain and/or nervous system, resulting in highly targeted, effective treatment. "While SCS benefits last as long as the device stimulates, and the pacemaker continually keeps the heart on path, we treat and hope to modify t...
Source: MDDI - July 25, 2018 Category: Medical Devices Authors: Heather R. Johnson Tags: Implants Electronics Source Type: news

At-Home, Wearable ECG Patch May Improve Early Detection of AF At-Home, Wearable ECG Patch May Improve Early Detection of AF
Continuous cardiac monitoring using a home-based, wearable electrocardiogram (ECG) sensor patch may improve early detection of atrial fibrillation (AF) in high-risk patients, new research shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 24, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Could supplemental oxygen help sleep apnoea patients?
Supplemental oxygen eliminates morning blood pressure rise in patients who stop using CPAP Related items fromOnMedica Obstructive sleep apnoea Sleep disorder linked to brain changes indicative of dementia Sleep apnoea in expectant mothers presents risk to newborns Sleep apnoea might increase risk of atrial fibrillation Oral device improves sleep apnoea and related symptoms (Source: OnMedica Latest News)
Source: OnMedica Latest News - July 23, 2018 Category: UK Health Source Type: news

AHA: ER Visits, Hospitalizations for AFib on the Rise
FRIDAY, July 20, 2018 (American Heart Association) -- Emergency room visits for atrial fibrillation are soaring. Added to the number of people admitted to the hospital for the condition, it's contributing to " an alarming growth " in its economic... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 20, 2018 Category: General Medicine Source Type: news

Boston Sci Just Won ’t Stop Buying Companies
There really doesn’t seem to be in sight to Boston Scientific’s recent buying spree. This time the Marlborough, Mass.-based company is picking up Claret Medical for about $220 million in upfront cash and a potential reimbursement-based milestone payment of up to $50 million. The deal is set to close sometime in the third quarter of 2018. Santa Rosa, CA-based Claret has developed and received clearance for the Sentinel Cerebral Embolic Protection System. The device is used to protect the brain during certain interventional procedures, predominately in patients undergoing transcatheter aortic valve replacement(TA...
Source: MDDI - July 20, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Cardiovascular Source Type: news

Boston Scientific puts $270m on the table for Claret Medical
Boston Scientific (NYSE:BSX) said today that it agreed to pay as much as $270 million to acquire Claret and its Sentinel device. Marlborough, Mass.-based Boston Scientific said the deal involves an ip-front cash payment of $220 million and another $50 million pegged to a reimbursement milestone. Claret’s Sentinel device is designed to trap and remove debris dislodged during transcatheter aortic valve replacements to prevent stroke and other neurological damage. After landing CE Mark approval in the European Union in 2014, Santa Rosa, Calif.-based Claret won de novo clearance from the FDA last year for the Sentin...
Source: Mass Device - July 20, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Mergers & Acquisitions Replacement Heart Valves Wall Street Beat Boston Scientific Claret Medical Inc. Source Type: news

Coffee and Atrial Fibrillation: What & #039;s the (True) Link?
A new study finds that higher caffeine intake may decrease the risk of patients developing new onset atrial fibrillation.   (Source: ConsultantLive)
Source: ConsultantLive - July 19, 2018 Category: Internal Medicine Authors: Veronica Hackenthal, MD Tags: Atrial Fibrillation Source Type: news

NIH director Collins touts AF detection capabilities of iRhythm ’ s Zio ECG patch
iRhythm Technologies‘ Zio ECG patch won praises from NIH Director Dr. Francis Collins this week for its ability to aid in the detection of atrial fibrillation. In an NIH Director blog post, Dr. Collins warned that while the dangers of atrial fibrillation are known, many individuals do not know they have atrial fibrillation and therefore cannot receive appropriate care. While doctors mainly screen for AFib by checking pulse, Dr. Collins recommended new mobile health technologies for detecting AF, including iRhythm’s Zio patch. Results from the mSToPS trial of the patch, which Dr. Collins referenced, indicated th...
Source: Mass Device - July 18, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular iRhythm Technologies Inc. Source Type: news

Trial Adds Gemcitabine to Pleural Mesothelioma HIOC Therapy
Results of a phase I clinical trial highlight how the addition of a drug to an existing treatment option appears safe and may improve outcomes in certain patients with malignant pleural mesothelioma (MPM). The primary goal of the trial was to determine the maximum tolerated dose of gemcitabine added to cisplatin when these drugs are delivered together as heated intraoperative chemotherapy (HIOC) during surgery. Researchers have studied cisplatin alone for HIOC. The addition of gemcitabine — a chemotherapy drug often used to treat pancreatic, ovarian and breast cancers — is new. The Journal of Thoracic Oncology...
Source: Asbestos and Mesothelioma News - July 18, 2018 Category: Environmental Health Authors: Matt Mauney Source Type: news

Immediate Monitoring With ECG Patch Ups A-Fib Diagnosis Rate
TUESDAY, July 17, 2018 -- Immediate monitoring with a self-applied wearable electrocardiogram (ECG) patch results in a higher rate of atrial fibrillation (AF) diagnosis among individuals at high risk, according to a study published in the July 10... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 17, 2018 Category: Pharmaceuticals Source Type: news

Smoking May Boost Risk of AFib
Smokers are at increased risk of atrial fibrillation, but the risk is reduced considerably in those who quit, researchers in Norway have found. (Source: WebMD Health)
Source: WebMD Health - July 16, 2018 Category: Consumer Health News Source Type: news

Smoking May Boost Atrial Fibrillation Risk
MONDAY, July 16, 2018 -- The more you smoke, the greater your chances of developing a common heart rhythm disorder that increases your risk of stroke and early death, researchers say. " If you smoke, stop smoking, and if you don't smoke, don't... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 16, 2018 Category: General Medicine Source Type: news

Afib Patch Test; Heart Failure and Genetics: It's PodMed Double T! (with audio)
(MedPage Today) -- This week's topics include a patch to diagnose atrial fibrillation, USPSTF recommendations on nontraditional risk factors for heart disease, the role of genetics in congestive heart failure, and multivitamins and heart disease. (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - July 14, 2018 Category: Cardiology Source Type: news

Smokers up to 45% more likely to suffer from irregular heart beats
Researchers from  Imperial College London found that for every 10 cigarettes smoked a day, the risk of suffering from atrial fibrillation, which is a cause of stroke, increases by 14 per cent. (Source: the Mail online | Health)
Source: the Mail online | Health - July 12, 2018 Category: Consumer Health News Source Type: news

Smokers are up to 45% more likely to suffer from deadly irregular heart beats, study finds
Researchers from  Imperial College London found that for every 10 cigarettes smoked a day, the risk of suffering from atrial fibrillation, which is a cause of stroke, increases by 14 per cent. (Source: the Mail online | Health)
Source: the Mail online | Health - July 12, 2018 Category: Consumer Health News Source Type: news

Smokers 'at much greater risk of suffering from an irregular heartbeat'
SMOKERS are at much greater risk of suffering from an irregular heartbeat that can trigger a stroke, warns new research. The study shows that each cigarette smoked increases the risk of atrial fibrillation, a heart condition that causes an irregular and often abnormally fast heart rate and affects one million Britons. (Source: Daily Express - Health)
Source: Daily Express - Health - July 12, 2018 Category: Consumer Health News Source Type: news

Asthma, Uncontrolled Asthma Associated With Risk of A-Fib
THURSDAY, July 12, 2018 -- There is a correlation for asthma and lack of asthma control with the risk of atrial fibrillation (AF), according to a study published online July 11 in JAMA Cardiology. Aivaras Cepelis, from the Norwegian University of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 12, 2018 Category: Pharmaceuticals Source Type: news

Atrial fibrillation: What is it? Six symptoms of the heart condition to watch out for
ATRIAL fibrillation is a heart condition that causes an irregular heartbeat. It is not usually life threatening, but can be uncomfortable and usually requires treatment. So what are the symptoms to look out for, and when should you see your GP? (Source: Daily Express - Health)
Source: Daily Express - Health - July 12, 2018 Category: Consumer Health News Source Type: news

The more you smoke, the greater your risk of a heart rhythm disorder
(European Society of Cardiology) The more you smoke, the greater your risk of a heart rhythm disorder called atrial fibrillation. That's the finding of a study published today in the European Journal of Preventive Cardiology, a European Society of Cardiology journal. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 12, 2018 Category: International Medicine & Public Health Source Type: news

CardioFocus launches HeartLight in Japan
CardioFocus said today it launched its HeartLight endoscopic ablation system in Japan in conjunction with its distribution partner JapanLifeline. The launch follows reimbursement approval the Marlborough, Mass.-based company won under Japan’s National Health Insurance this month, after having won regulatory approval with the Japanese Ministry of Health, Labour and Welfare last July. The HeartLight system is designed to allow electrophysiologists to control the delivery of laser energy through direct visual guidance to isolate pulmonary veins with a high procedural flexibility. The device includes a compliant balloon ...
Source: Mass Device - July 11, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular CardioFocus Inc. Source Type: news

RE-LY: NSAIDs Plus Anticoagulants a Dangerous Combination RE-LY: NSAIDs Plus Anticoagulants a Dangerous Combination
The authors caution against using an NSAID with oral anticoagulants in patients with atrial fibrillation after finding an increased risk for bleeding and stroke.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 11, 2018 Category: Consumer Health News Tags: Cardiology News Source Type: news

RE-LY: NSAIDs Plus Anticoagulants a Dangerous Combination RE-LY: NSAIDs Plus Anticoagulants a Dangerous Combination
The authors caution against using an NSAID with oral anticoagulants in patients with atrial fibrillation after finding an increased risk for bleeding and stroke.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 11, 2018 Category: Cardiology Tags: Cardiology News Source Type: news

Medtronic & #039;s Value-Based Partnerships are Paying Off in Spades
Dublin, Ireland-based Medtronic continues to lead the charge toward value-based care, and it's beginning to pay off in a big way.  One of the company's value-based care partners, UnitedHealthcare, has seen a 27% decline in the rate of preventable hospital admissions for Medtronic insulin pump users compared to patients on multiple daily insulin injections, according to an analysis of more than 6,000 members with diabetes on Medtronic MiniMed 630G and previous generation insulin pumps. And that's just in the first year of the partnership. The analysis included a mix of members using both standalone insulin pumps and pu...
Source: MDDI - July 11, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

What is the association between asthma and atrial fibrillation risk?
(JAMA Network) Researchers report moderately increased risks for atrial fibrillation (AF), an irregular and often rapid heart rate, in adults with asthma   and a lack of asthma control in a study that included about 54,000 individuals   in Norway, although underlying causes for the association still need to be understood. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 11, 2018 Category: International Medicine & Public Health Source Type: news

Wearable, At-Home Patch Could Spot A-Fib Early
A wearable patch could help doctors diagnose atrial fibrillation faster. (Source: WebMD Health)
Source: WebMD Health - July 10, 2018 Category: Consumer Health News Source Type: news

If You Look For Atrial Fibrillation You Will Find Atrial Fibrillation
If you look hard to find people who have atrial fibrillation you will find atrial fibrillation. But a new study offers no evidence whatsoever that the new diagnosis improves outcomes, though it does find that the diagnosis leads to increased use of drugs and procedures. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 10, 2018 Category: Pharmaceuticals Authors: Larry Husten, Contributor Tags: NYSE:JNJ NYSE:BMS NYSE:PFE Source Type: news

Study: Prompt monitoring with wearable ECG patch more frequently detects undiagnosed a-fib
A take-home wearable ECG could be key in detecting undiagnosed atrial fibrillation, according to a new study published in JAMA this morning. Researchers from The Scripps Research Institute used the iRhythm Zio patch, an ECG screening wearable, to monitor patients with a risk for the condition.   (Source: mobihealthnews)
Source: mobihealthnews - July 10, 2018 Category: Information Technology Source Type: news

Wearable, At-Home Patch Could Spot Your A-Fib Early
TUESDAY, July 10, 2018 -- The common but dangerous heart rhythm disorder known as atrial fibrillation -- or a-fib -- can go undetected for years. Now, research suggests a high-tech, wearable patch might spot the condition early. Use of the Zio XT... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 10, 2018 Category: General Medicine Source Type: news

XANTUS programme confirms low bleeding and low stroke rate with Xarelto ® in 11,121 prospectively investigated patients with atrial fibrillation
Results from an analysis of Bayer's XANTUS programme were recently published in the Journal of the American College of Cardiology (JACC)(1). The data confirm the safety profile of the oral Factor Xa inhibitor Xarelto® (rivaroxaban) in routine clinical practice. The analysis highlighted low bleeding and low stroke rates in patients with atrial fibrillation (AF) treated with Xarelto, as well as low rates of treatment discontinuation. (Source: World Pharma News)
Source: World Pharma News - July 10, 2018 Category: Pharmaceuticals Tags: Featured Bayer Business and Industry Source Type: news

Biodesix Deal Adds to Active M & amp;A Day for Medtech
Biodesix made a move to expand its lung testing franchise on a day already buzzing with M&A activity. The Boulder, CO-based company said it was acquiring Integrated Diagnostics for an undisclosed sum. The agreement includes the XL2 test, Seattle, WA-based lead oncology product, which offers a noninvasive means of ruling out cancer for patients with suspicious lung nodules. The XL2 test, which requires a simple blood draw, is a pulmonary nodule classifier that measures proteins to identify lung nodules that have a high probability of being benign. “The team at Indi has developed and substantially validated an impo...
Source: MDDI - July 10, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Catheter Ablation Effective for AFib in Adults with Congenital Heart Disease
The first study of its kind found ablation strategies used in normal hearts are safe, effective, and yield good results. (Source: ConsultantLive)
Source: ConsultantLive - July 9, 2018 Category: Internal Medicine Authors: Payal Kohli, MD Tags: Atrial Fibrillation Source Type: news